Molly O. Regelmann

18 papers receiving 291 citations

Peers

Molly O. Regelmann
Comparison fields: 5 of 57
  • Molecular Biology 115
  • Endocrinology, Diabetes and Metabolism 103
  • Pediatrics, Perinatology and Child Health 77
  • Clinical Biochemistry 65
  • Genetics 57
Replace Frédérique Gatelais with:
Frédérique Gatelais France
Laura Prieto Argentina
Hugo Rocha Portugal
Chengyan Xu China
Marilyn L. Scott United States
Madeline Thornton United States
Blaž Krhin Slovenia
Sophie Christin-Maître France
Pietro Lazzeroni Italy
Pınar İşgüven Türkiye
Molly O. Regelmann relative to Frédérique Gatelais France Frédérique Gatelais's profile →
Citations per field
00.5×4.4×
Frédérique Gatelais · 1×
Citations per year

Countries citing papers authored by Molly O. Regelmann

Since Specialization
Citations

This map shows the geographic impact of Molly O. Regelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly O. Regelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly O. Regelmann more than expected).

Fields of papers citing papers by Molly O. Regelmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly O. Regelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly O. Regelmann. The network helps show where Molly O. Regelmann may publish in the future.

Co-authorship network of co-authors of Molly O. Regelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Molly O. Regelmann. A scholar is included among the top collaborators of Molly O. Regelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly O. Regelmann. Molly O. Regelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 3
2 3
3 6
4 22
5 13
6 9
7 11
8 1
9 35
10 64
11 37
12 10
13 2
14 3
15 45
16 14
17 19
18 4

About Molly O. Regelmann

Molly O. Regelmann is a scholar working on Endocrinology, Diabetes and Metabolism, Clinical Biochemistry and Transplantation, having authored 18 papers that have together received 301 indexed citations. Recurring topics across this work include Adrenal Hormones and Disorders (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Neonatal Health and Biochemistry (3 papers). The work is most often cited by research in Clinical Biochemistry (65 citations), Endocrinology, Diabetes and Metabolism (103 citations) and Obstetrics and Gynecology (36 citations). Molly O. Regelmann has collaborated with scholars based in United States and Australia. Frequent co-authors include Robert Rapaport, Daniel Zeve, Ian R. Holzman, Elizabeth Chacko, Gertrude Costin, Manmohan K. Kamboj, Ronen Arnon, Kyriakie Sarafoglou, Takara L. Stanley and Nanda Kerkar. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, PEDIATRICS and The Journal of Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026